Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP501946.RATk-wxeAVtQLJa-EOo-5UlbOBgTskdmvoYDLKrZQsPRQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP501946.RATk-wxeAVtQLJa-EOo-5UlbOBgTskdmvoYDLKrZQsPRQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP501946.RATk-wxeAVtQLJa-EOo-5UlbOBgTskdmvoYDLKrZQsPRQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP501946.RATk-wxeAVtQLJa-EOo-5UlbOBgTskdmvoYDLKrZQsPRQ130_provenance.
- NP501946.RATk-wxeAVtQLJa-EOo-5UlbOBgTskdmvoYDLKrZQsPRQ130_assertion description "[The standard treatments for chronic lymphocytic leukemia (CLL) include the alkylating agent chlorambucil (CLB) and the nucleoside analog fludarabine (F-ara-AMP, Flu).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP501946.RATk-wxeAVtQLJa-EOo-5UlbOBgTskdmvoYDLKrZQsPRQ130_provenance.
- NP501946.RATk-wxeAVtQLJa-EOo-5UlbOBgTskdmvoYDLKrZQsPRQ130_assertion evidence source_evidence_literature NP501946.RATk-wxeAVtQLJa-EOo-5UlbOBgTskdmvoYDLKrZQsPRQ130_provenance.
- NP501946.RATk-wxeAVtQLJa-EOo-5UlbOBgTskdmvoYDLKrZQsPRQ130_assertion SIO_000772 14614459 NP501946.RATk-wxeAVtQLJa-EOo-5UlbOBgTskdmvoYDLKrZQsPRQ130_provenance.
- NP501946.RATk-wxeAVtQLJa-EOo-5UlbOBgTskdmvoYDLKrZQsPRQ130_assertion wasDerivedFrom befree-20140225 NP501946.RATk-wxeAVtQLJa-EOo-5UlbOBgTskdmvoYDLKrZQsPRQ130_provenance.
- NP501946.RATk-wxeAVtQLJa-EOo-5UlbOBgTskdmvoYDLKrZQsPRQ130_assertion wasGeneratedBy ECO_0000203 NP501946.RATk-wxeAVtQLJa-EOo-5UlbOBgTskdmvoYDLKrZQsPRQ130_provenance.
- befree-20140225 importedOn "2014-02-25" NP501946.RATk-wxeAVtQLJa-EOo-5UlbOBgTskdmvoYDLKrZQsPRQ130_provenance.